Stephane Bancel, Moderna, CEO
Stephane Bancel, Moderna, CEO
Building A Biotech Company Around a New Technology: Lessons and Thoughts
Building A Biotech Company Around a New Technology: Lessons and Thoughts
26 Feb 201612:00 PM – 1:30 PM
Moderna is a clinical stage biotech company started in July 2011 whose mission is
to deliver on the promise of mRNA science to bring dozens of new innovative drugs
to patients. In just over four years, the team has grown to 340 employees, partnered with Astra-Zeneca,
Merck, Alexion, DARPA and the Gates Foundation, raised $1.2 Billion, half through
equity and half through partner technology access fees and milestones. Stephane will
describe some of the challenges he and his team faced building moderna, where the
company is going, and the challenges ahead.
Location:
Baker Library | Bloomberg Center 102
Organizer: